SCHEMBL14129672

SCHEMBL14129672

CC(C)(C)C(=O)c1cn2c(c(O)c1=O)C(=O)N(Cc1ccc(F)c(Cl)c1)CC2

nearest known ligand 0.44

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.38
FSCN1 Q16658 1/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
AKR1B1 P15121 1/20 0.35
SLC22A2 O15244 2/20 0.35
ERCC1 P07992 1/20 0.35
ERCC4 Q92889 1/20 0.35
HTR2A P28223 1/20 0.34
GRM2 Q14416 1/20 0.34
CYP3A4 P08684 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4316304 0.99 PIK3CA (0.38) PIK3CAFSCN1KDM4EALDH1A1HPGD
SCHEMBL4320857 0.91 DRD3 (0.36) PIK3CAKDM4EALDH1A1HPGDHTT
SCHEMBL4328517 0.88 AKR1B1 (0.40) ALDH1A1HTTAKR1B1
SCHEMBL4324086 0.87 FSCN1 (0.36) PIK3CAFSCN1KDM4EALDH1A1HPGD
SCHEMBL4326204 0.87 SLC22A2 (0.42) FSCN1KDM4EALDH1A1HPGDHTT
SCHEMBL4328767 0.87 P2RX7 (0.42) PIK3CAKDM4EALDH1A1HPGDHTT
Hydrochloric Acid SCHEMBL4320718 0.86 P2RX7 (0.41) PIK3CAKDM4EALDH1A1HPGDHTT
SCHEMBL4326707 0.86 P2RX7 (0.41) PIK3CAKDM4EALDH1A1HPGDHTT
SCHEMBL14107105 0.85 FSCN1 (0.41) PIK3CAFSCN1KDM4EALDH1A1HPGD
SCHEMBL14129674 0.82 KDM4E (0.38) FSCN1KDM4EALDH1A1HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080161311-A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. 2008-07-03 US disclosed
US-20080161311-A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. 2008-07-03 US disclosed
US-7211572-B2 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2007-05-01 US disclosed
US-7211572-B2 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor JAPAN TOBACCO INC. (JP) 2007-05-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080161311-A1 Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor DNTT, PNP, NNMT PIK3CA 654/4885FSCN1 4824/4885KDM4E 627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.